Physicians need to inform parents about the limited effectiveness of growth hormone therapy in satisfying the treatment goals of children with idiopathic short stature.
Physicians need to inform parents about the limited effectiveness of growth hormone therapy in satisfying the treatment goals of children with idiopathic short stature.
Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication.
Physicians of patients who request physician-assisted suicide should not avoid the subject and should try to discuss the patients' specific concerns and fears with them.
Physicians of patients who request physician-assisted suicide should not avoid the subject and should try to discuss the patients' specific concerns and fears with them.
Physicians need to inform parents about the limited effectiveness of growth hormone therapy in satisfying the treatment goals of children with idiopathic short stature.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.
When serving an ethnically diverse population, it is imperative that physicians have an understanding of a patients' cultural background and attitudes towards health, nutrition and personal care.